Sequence-Based Identification of Metronidazole-Resistant Clostridioides difficile Isolates

Insights

The pCD-METRO plasmid causes metronidazole resistance in Clostridioides difficile. This plasmid is widespread in clinical and veterinary settings in the Americas, necessitating detection via PCR or genomic assays.

Area of Science:

  • Microbiology
  • Genetics
  • Infectious Diseases

Background:

  • Clostridioides difficile is an opportunistic pathogen causing significant healthcare-associated infections.
  • Metronidazole is a key antibiotic for treating C. difficile infections.
  • Emergence of antibiotic resistance in C. difficile poses a therapeutic challenge.

Purpose of the Study:

  • To characterize the pCD-METRO plasmid responsible for metronidazole resistance in C. difficile.
  • To investigate the prevalence and distribution of pCD-METRO in clinical and veterinary isolates.
  • To recommend diagnostic strategies for identifying metronidazole-resistant C. difficile.

Main Methods:

  • Plasmid sequencing and comparative analysis.
  • Isolate screening from clinical and veterinary sources.
  • Development and validation of molecular detection methods (PCR, genomic assays).

Main Results:

  • High sequence similarity was observed among pCD-METRO plasmids from diverse isolates.
  • The pCD-METRO plasmid and associated resistant C. difficile strains were identified in reservoirs across the Americas.
  • The presence of pCD-METRO correlates with metronidazole resistance.

Conclusions:

  • The pCD-METRO plasmid is a significant driver of metronidazole resistance in C. difficile.
  • Widespread dissemination of pCD-METRO in both human and animal populations necessitates surveillance.
  • Molecular detection methods like PCR are recommended for timely identification of resistant strains.